The Femtech Market encompasses a range of technology-driven products, services, and software solutions focused on women’s health, covering areas such as menstrual health, fertility tracking, pregnancy care, menopause management, and reproductive health disorders. The term “Femtech” (female technology) represents the intersection of healthcare and technology aimed at addressing women-specific health needs that have historically been underrepresented in medical research and innovation. Market growth is driven by increasing awareness of women’s health issues, rising smartphone penetration, and growing demand for personalized and digital healthcare solutions.

According to Fortune Business Insights, the femtech market share was valued at USD 7.81 billion in 2024 and is projected to grow from USD 9.12 billion in 2025 to USD 28.89 billion by 2032, exhibiting a CAGR of 17.9% during the forecast period. North America dominated the market, accounting for a 53.64% share in 2024.

Top Companies in the Femtech Market

• Flo Health Inc. (U.K.)
• Chiaro Technology Limited (U.K.)
• Natural Cycles USA Corp (U.S.)
• BioWink GmbH (Germany)
• FemTec Health (U.S.)
• Glow, Inc. (U.S.)
• HeraMed (Israel)
• Joylux, Inc. (U.S.)
• Coroflo Ltd. (Ireland)

Market Drivers & Restraints

Drivers:

• Rising prevalence of women’s health conditions such as menstrual disorders, fertility challenges, and menopause-related issues.
• Growing adoption of digital health solutions and mobile applications for period tracking, fertility management, and wellness monitoring.
• Increasing funding from investors and venture capital firms supporting women-led healthcare innovations.
• Integration of artificial intelligence and wearable technology in women’s health diagnostics and preventive care.

Restraints: